Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Voyager Therapeutics
(NASDAQ:VYGR)
Intraday
$8.81
0.28
[3.28%]
After-Hours
$8.81
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$8.81
0.28
[3.28%]
At close: May 3
$8.81
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Voyager Therapeutics Stock (NASDAQ:VYGR)
Voyager Therapeutics Stock (NASDAQ: VYGR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, May 03, 2024
Puma Biotechnology's Q1 Earnings and Revenues Beat
Zacks
-
2 days ago
Monday, April 22, 2024
Voyager Therapeutics To Present Translational Data For IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials At ASGCT 27th Annual Meeting
Benzinga Newsdesk
-
Apr 22, 2024, 4:31PM
Tuesday, April 16, 2024
Selection Of The Development Candidate Triggered A $3M Milestone Payment To Voyager, Which The Company Expects To Receive In Q2 Of 2024
Benzinga Newsdesk
-
Apr 16, 2024, 7:12AM
Voyager Therapeutics And Neurocrine Biosciences Expect To File An FDA Investigational New Drug Application For GBA1 Program Candidate In 2025
Benzinga Newsdesk
-
Apr 16, 2024, 7:07AM
Voyager Therapeutics And Neurocrine Biosciences Have Selected Lead Development Candidate In GBA1 Gene Therapy Program For Potential Treatment Of Parkinson's Disease And Other GBA1-mediated Diseases
Benzinga Newsdesk
-
Apr 16, 2024, 7:06AM
Tuesday, April 02, 2024
Voyager Therapeutics Said Co And CFO Peter P. Pfreundschuh Entered Into A Transition, Separation And Release Of Claims Agreement; Pfreundschuh Resigned From His Position AsCFO Effective On April 12, 2024
Charles Gross
-
Apr 2, 2024, 4:36PM
Tuesday, March 26, 2024
Voyager Therapeutics shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and a price target of $22.
Benzinga Newsdesk
-
Mar 26, 2024, 7:12AM
Guggenheim Initiates Coverage On Voyager Therapeutics with Buy Rating, Announces Price Target of $22
Benzinga Newsdesk
-
Mar 26, 2024, 6:39AM
Tuesday, March 19, 2024
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
Vandana Singh
-
Mar 19, 2024, 2:16PM
Voyager Therapeutics shares are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced a $30 price target.
Benzinga Newsdesk
-
Mar 19, 2024, 11:25AM
HC Wainwright & Co. Initiates Coverage On Voyager Therapeutics with Buy Rating, Announces Price Target of $30
Benzinga Newsdesk
-
Mar 19, 2024, 6:50AM
Thursday, March 07, 2024
Citigroup Initiates Coverage On Voyager Therapeutics with Buy Rating, Announces Price Target of $16
Benzinga Newsdesk
-
Mar 7, 2024, 3:49AM
Thursday, February 29, 2024
Voyager Therapeutics shares are trading lower following Q4 earnings.
Benzinga Newsdesk
-
Feb 29, 2024, 11:40AM
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
Piero Cingari
-
Feb 29, 2024, 9:20AM
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 29, 2024, 8:04AM
Wednesday, February 28, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Feb 28, 2024, 4:31PM
Voyager Therapeutics: Q4 Earnings Insights
Benzinga Insights
-
Feb 28, 2024, 4:30PM
Voyager Therapeutics Q4 2023 GAAP EPS $1.25 Beats $(0.29) Estimate, Sales $90.06M Beat $20.64M Estimate
Benzinga Newsdesk
-
Feb 28, 2024, 4:27PM
Earnings Scheduled For February 28, 2024
Benzinga Insights
-
Feb 28, 2024, 6:24AM
Tuesday, February 27, 2024
Earnings Preview For Voyager Therapeutics
Benzinga Insights
-
Feb 27, 2024, 1:01PM
Monday, February 26, 2024
Selection Of The Development Candidate For Friedreich's Ataxia in Collaboration with Neurocrine Biosciences Triggered $5M Milestone Payment To Voyager, Which It Expects To Receive In The First Quarter Of 2024
Benzinga Newsdesk
-
Feb 26, 2024, 7:14AM
Voyager Therapeutics Announced That The Joint Steering Committee With Its Collaborator Neurocrine Biosciences Has Selected A Lead Development Candidate In Friedreich's Ataxia Program. The Companies Expect The Program To Advance Into Human Trials In 2025
Benzinga Newsdesk
-
Feb 26, 2024, 7:12AM
Tuesday, February 20, 2024
Voyager Therapeutics Reports Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer's Disease and Advances Program into Late Research
Benzinga Newsdesk
-
Feb 20, 2024, 7:09AM
Monday, February 05, 2024
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
-
Feb 5, 2024, 9:44AM
Monday, January 08, 2024
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
-
Jan 8, 2024, 9:44AM
Friday, January 05, 2024
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Jan 5, 2024, 1:13PM
Voyager Therapeutics shares are trading lower after the company announced the pricing of its $100 million offering of 7,777,778 shares at $9 per share.
Benzinga Newsdesk
-
Jan 5, 2024, 11:32AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Jan 5, 2024, 8:05AM
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 5, 2024, 8:03AM
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
-
Jan 5, 2024, 6:19AM
Voyager Therapeutics Prices Public Offering Of 7,777,778 Common Shares At $9/Share
Benzinga Newsdesk
-
Jan 5, 2024, 1:28AM
Thursday, January 04, 2024
Voyager Therapeutics Stock Tanked After-Hours - Here's Why
Ryan Gustafson
-
Jan 4, 2024, 5:08PM
Voyager Therapeutics shares are trading lower after the company announced a proposed public offering of $100 million.
Benzinga Newsdesk
-
Jan 4, 2024, 4:34PM
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Jan 4, 2024, 4:31PM
Voyager Therapeutics Announces Proposed Public Offering Of $100M
Benzinga Newsdesk
-
Jan 4, 2024, 4:14PM
Wednesday, January 03, 2024
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 3, 2024, 12:58PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jan 3, 2024, 12:31PM
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Jan 3, 2024, 10:24AM
Tuesday, January 02, 2024
Crude Oil Down 2%; Tesla Deliveries Top Estimates
Avi Kapoor
-
Jan 2, 2024, 2:17PM
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 2, 2024, 1:35PM
Wells Fargo Upgrades Voyager Therapeutics to Overweight, Raises Price Target to $14
Benzinga Newsdesk
-
Jan 2, 2024, 1:27PM
Dow Turns Higher; Anavex Life Sciences Shares Plunge
Avi Kapoor
-
Jan 2, 2024, 12:15PM
Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today?
Vandana Singh
-
Jan 2, 2024, 9:50AM
Voyager Therapeutics shares are trading higher after the company announced a strategic collaboration and capsid license agreement with Novartis to advance potential gene therapies for Huntington's disease and spinal muscular atrophy.
Benzinga Newsdesk
-
Jan 2, 2024, 8:58AM
Market-Moving News for January 2nd
Benzinga Newsdesk
-
Jan 2, 2024, 8:42AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 2, 2024, 8:05AM
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies
Benzinga Newsdesk
-
Jan 2, 2024, 7:02AM
Monday, December 11, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
-
Dec 11, 2023, 9:43AM
Wednesday, December 06, 2023
Voyager Therapeutics Has Selected A Lead Development Candidate For Its Superoxide Dismutase 1-mutated Amyotrophic Lateral Sclerosis Gene Therapy Program; FDA Investigational New Drug Application Filing Anticipated In Mid-2025
Benzinga Newsdesk
-
Dec 6, 2023, 7:16AM
Monday, November 27, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
-
Nov 27, 2023, 9:43AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch